Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2

• Published in: Cardiovascular research Vol. 49; no. 3; pp. 659 - 670
• Main Authors: TEICHERT-KULISZEWSKA, Krystyna, MAISONPIERRE, Peter C, JONES, Nina, CAMPBELL, Andrew I. M, MASTER, Zubin, BENDECK, Michelle P, ALITALO, Kari, DUMONT, Daniel J, YANCOPOULOS, George D, STEWART, Duncan J
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 16.02.2001
• Subjects: Analysis of Variance; Angiopoietin-1; Angiopoietin-2; Animals; Aorta; Biological and medical sciences; Blood vessels and receptors; Blotting, Western; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular - metabolism; Enzyme Inhibitors - pharmacology; Fundamental and applied biological sciences. Psychology; Gels; Gene Transfer Techniques; Humans; Membrane Glycoproteins - genetics; Membrane Glycoproteins - pharmacology; Models, Biological; Muscle, Smooth, Vascular - blood supply; Neoplasm Proteins - metabolism; Neovascularization, Physiologic; Proteins - genetics; Proteins - pharmacology; Proto-Oncogene Proteins; Rats; Receptor Protein-Tyrosine Kinases - antagonists & inhibitors; Receptor, TIE-2; Vertebrates: cardiovascular system; Human; Tyrosine; Angiogenesis; Cell culture; Enzyme; Kinase; Transferases; Blood vessel; Extracellular matrix; Physiology; Circulatory system; Biological receptor
• ISSN: 0008-6363; 1755-3245
• DOI: 10.1016/s0008-6363(00)00231-5

The endothelial cell (EC) specific tyrosine kinase receptor, Tie2, interacts with at least two ligands, angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2). Ang1 stimulates Tie2 receptor autophosphorylation, while Ang2 has been reported to inhibit Ang1-induced Tie2 receptor autophosphorylation. We studied the effects of Ang1 and Ang2 in an in vitro model of angiogenesis. Human ECs (HUVEC), cultured on 3-D fibrin matrices, were treated with conditioned media (CM) from stably transfected cells expressing human Ang1 or Ang2, or with purified recombinant proteins. EC tube formation was measured as a differentiation index (DI), calculated as the ratio of total tube length over residual of EC monolayer. CM from Ang1 overexpressing A10 SMC or HEK293T cells induced profound HUVEC differentiation, resulting in the formation of extensive capillary-like tubes within 48 h (DI: 24.58+/-5.91 and 19.13+/-7.86, respectively) vs. control (DI: 2.73+/-1.68 and 2.15+/-1.45, respectively, both P<0.001). Interestingly, CM from two independent cell lines overexpressing Ang2 also produced a significant increase in EC differentiation (DI: 9.22+/-3.00 and 9.72+/-4.84, both P<0.005 vs. control) although the degree of angiogenesis was significantly less then that seen with Ang1. Addition of Ang1* (a genetically engineered variant of naturally occurring Ang1) or Ang2 also resulted in dose dependent increases in DI, which were blocked by an excess of soluble Tie2 receptor (20 microg/ml). Both Ang1* and Ang2 induced modest increases in [3H]thymidine incorporation into HUVECs (20 and 26%, respectively), which were inhibited by excess soluble Tie2. Although Ang2 was unable to induce significant Tie2 receptor phosphorylation during a 5-min exposure, a 24-h pretreatment with Ang2, followed by brief re-exposure, produced Tie2 phosphorylation in HUVEC comparable to that produced by Ang1*. These results demonstrate for the first time that Ang2 may have a direct role in stimulating Tie2 receptor signaling and inducing in vitro angiogenesis. Our findings suggest that the physiological role of Ang2 is more complex than previously recognized: acting alternately to promote or blunt Tie2 receptor signaling in endothelial cells, depending on local conditions.